Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
PF-06826647 is an inhibitor of tyrosine kinase 2 (TYK2; IC50 = 15 nM).1 It is selective for TYK2 over JAK1, JAK2, and JAK3 (IC50s = 383, 74, and >10,000 nM, respectively). PF-06826647 inhibits IL-12-induced phosphorylation of STAT4 in isolated human whole blood (IC50 = 14 nM). In vivo, PF-06826647 (3-30 mg/kg, p.o.) reduces ear edema in a mouse model of skin inflammation induced by the toll-like receptor 7 (TLR7) agonist imiquimod (Item No. 14956).
WARNING This product is not for human or veterinary use.
1. Discovery of tyrosine kinase 2 (TYK2) inhibitor (PF-